ZoomRx
Buying intent
24 tracked signals | Top 11 topics are below | Marketing and Operations are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere ZoomRx's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
4d ago
11d ago
4d ago
20d ago
13d ago
26d ago
26d ago
26d ago
26d ago
26d ago
26d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at ZoomRx
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileZoomRx is a strategic life sciences consultancy that empowers pharma and biotech companies to achieve clarity in bringing their drugs to market. We combine human expertise with AI innovation, proprietary data assets, and deep life science knowledge to help pharmaceutical and biotechnology companies optimize their market strategies and navigate the future of drug development with confidence. With
Top accounts researching ZoomRx
names withheld on the public pageThese are companies whose own people brought up ZoomRx unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
30,546 companies · 119,561 people are researching Agentic AI System
ZoomRx's own team shows 5 signals on this topic. No one outside ZoomRx has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Decision Intelligence776 cos · 2,013 people
- Artificial Intelligence129,094 cos · 649,540 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Leadership — 1 person; Product — 1 person
What's been said
public posts mentioning ZoomRxUp to 9 public excerpts naming ZoomRx from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
When insight cycles stretch to 6–12 weeks, you’re reacting to a version of the market that’s already changed. This is exactly the problem we’ve been focused on solving at ZoomRx - compressing that cycle from weeks to days, so teams can actually act while it still matters. In a launch window, that lag adds up quickly.
Apr 2026I spend most of my time looking at why some launches perform against their KPIs and others don't. One pattern comes up consistently. It's not bad research. It's research that was never designed to connect. ATU, PET, PCA, HCP-Patient dialogue each running through a separate vendor, recruiting separate doctors, delivering separate reports. On paper it looks comprehensive. But you can't trace the chain that actually defines launch success: did our spend reach the right doctors, shift their perception, and turn into prescriptions? You end up with data everywhere and a coherent story nowhere. We call this the Silo Trap. It's the first of five structural failure modes we've mapped across pharma launch brands. Read more👉 https://lnkd.in/gpNcN6Tm #LaunchExcellence #MarketResearch #DrugLaunch #BioPharma #ZoomRx #5SilentKillers
Apr 2026